Hims & Hers Health (HIMS) News Today → [PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy (From DeFi Distribution) (Ad) Free HIMS Stock Alerts $21.59 +0.80 (+3.85%) (As of 01:24 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 7:25 AM | marketbeat.com3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & HersOne of the market's most closely watched economic reports made a sudden turn last week. The employment situation report (NFP) showed that the U.S. economy is still resiliently adding jobs despite seeing some contradicting indicators placing a ceiling on its growth.June 10 at 7:25 AM | marketbeat.com3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers (HIMS)These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are realJune 10 at 4:41 AM | seekingalpha.comBeyond The Marketing Machine: Why Hims & Hers Stock Might Be VulnerableJune 9 at 5:32 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Shares Down 1.9% June 8 at 7:00 AM | marketbeat.comMarketBeat Week in Review – 6/3 - 6/7 (HIMS)Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next weekJune 8 at 2:02 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Trading Down 1.7% on Insider SellingJune 7 at 7:58 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Sets New 52-Week High at $21.55June 7 at 1:16 AM | americanbankingnews.comHims & Hers Health Target of Unusually Large Options Trading (NYSE:HIMS)June 6, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading Down 1.7% After Insider SellingHims & Hers Health (NYSE:HIMS) Trading Down 1.7% on Insider SellingJune 6, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird Sells 17,625 SharesJune 6, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 188,888 SharesJune 6, 2024 | americanbankingnews.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $2,664,656.85 in StockJune 5, 2024 | marketbeat.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) COO Sells 17,625 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) COO Melissa Baird sold 17,625 shares of the firm's stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $20.42, for a total transaction of $359,902.50. Following the sale, the chief operating officer now directly owns 541,432 shares of the company's stock, valued at approximately $11,056,041.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.June 5, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Up 3.1%Hims & Hers Health (NYSE:HIMS) Trading 3.1% HigherJune 5, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Reaches New 12-Month High at $21.55Hims & Hers Health (NYSE:HIMS) Hits New 1-Year High at $21.55June 5, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Shares Purchased by Dimensional Fund Advisors LPDimensional Fund Advisors LP increased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 9.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,147,927 shares of the company's stockJune 5, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Stock Price Down 1.2% Following Insider SellingJune 4, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Down 1.2% on Insider SellingHims & Hers Health (NYSE:HIMS) Stock Price Down 1.2% Following Insider SellingJune 4, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Price Target Increased to $22.00 by Analysts at Bank of AmericaJune 4, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Trading 6.5% Higher on Analyst UpgradeJune 3, 2024 | marketbeat.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 129,667 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 129,667 shares of the company's stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $20.55, for a total transaction of $2,664,656.85. Following the transaction, the insider now owns 156,855 shares in the company, valued at approximately $3,223,370.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.June 3, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading 6.5% Higher Following Analyst UpgradeHims & Hers Health (NYSE:HIMS) Trading Up 6.5% Following Analyst UpgradeJune 3, 2024 | marketbeat.comHims & Hers Health Soars on Generic GLP-1 Rollout PlansHim & Hers Health Inc. NYSE: HIMS provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments for erectile dysfunction (ED) through brand and generic versions of Pfizer Inc. NYSE: PFE Viagra (Sildenafil) and Eli Lilly & Co. NYSE: LLY Cialis (Tadalafil).June 3, 2024 | marketbeat.comHims & Hers Health Soars on Generic GLP-1 Rollout Plans Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatmentsJune 2, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Trading Down 2.7%June 2, 2024 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Sees Significant Increase in Short InterestJune 2, 2024 | americanbankingnews.comBrokerages Set Hims & Hers Health, Inc. (NYSE:HIMS) Price Target at $15.69June 1, 2024 | fool.comHims & Hers Health Stock Soared This Week: Here's WhyJune 1, 2024 | americanbankingnews.comFinancial Comparison: Hims & Hers Health (NYSE:HIMS) and Auna (NYSE:AUNA)May 31, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Stock Price Down 2.7%Hims & Hers Health (NYSE:HIMS) Stock Price Down 2.7%May 31, 2024 | insidertrades.comSoleil Boughton Sells 2,502 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockMay 31, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Short Interest Up 20.3% in MayHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 22,130,000 shares, a growth of 20.3% from the April 30th total of 18,390,000 shares. Currently, 14.7% of the company's stock are sold short. Based on an average daily trading volume, of 8,300,000 shares, the short-interest ratio is presently 2.7 days.May 30, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Reaches New 52-Week High at $21.16Hims & Hers Health (NYSE:HIMS) Sets New 1-Year High at $21.16May 30, 2024 | marketbeat.comCall Option Volumes Spiked For These 3 StocksAs the saying goes, always follow the money. This time, investors can follow the proverbial big players through an options activity screener, spotting unusual trends in how markets are betting.May 30, 2024 | marketbeat.comCall Option Volumes Spiked For These 3 Stocks (HIMS)Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decisionMay 30, 2024 | marketbeat.comTrexquant Investment LP Purchases New Shares in Hims & Hers Health, Inc. (NYSE:HIMS)Trexquant Investment LP acquired a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 124,469 shares of the company's stock, valued at approxMay 30, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) have been given an average rating of "Moderate Buy" by the fifteen brokerages that are covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and eight have issued a buyMay 29, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $43,359.66 in StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 2,502 shares of the firm's stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $17.33, for a total value of $43,359.66. Following the transaction, the insider now directly owns 156,855 shares of the company's stock, valued at $2,718,297.15. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 29, 2024 | benzinga.comSmart Money Is Betting Big In HIMS OptionsMay 28, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading VolumeHims & Hers Health (NYSE:HIMS) Sees Large Volume IncreaseMay 28, 2024 | marketbeat.comLifeMD Can Surge on Its GLP-1 Offerings (HIMS)LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a resultMay 26, 2024 | fool.comThe Ultimate Growth Stock to Buy With $20 Right NowMay 24, 2024 | theglobeandmail.comIs Hims & Hers Stock a Buy for GLP-1 Upside?May 24, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading Up 5.7%Hims & Hers Health (NYSE:HIMS) Trading 5.7% HigherMay 24, 2024 | investorplace.com7 Stocks to Dominate in the Next Economic UpturnMay 23, 2024 | msn.comHims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDAMay 23, 2024 | msn.comCitigroup Downgrades Hims & Hers Health (HIMS)May 23, 2024 | markets.businessinsider.comNavigating 10 Analyst Ratings For Hims & Hers HealthMay 23, 2024 | investorplace.comMove Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.May 22, 2024 | finance.yahoo.comNvidia earnings, housing market outlook, BNPL regulatory pressure: Market Domination Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address [PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy (Ad)The crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially profit from this trillion-dollar niche WITHOUT buying a single coin, NFT or investing in ANYTHING. Grab the PDF here for free: Related Videos HIMS Media Mentions By Week HIMS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.480.76▲Average Medical News Sentiment HIMS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼268▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TDOC News Today AUNA News Today LFMD News Today AIRS News Today SHLT News Today TOI News Today CCM News Today HOLX News Today BAX News Today LH News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
